Literature DB >> 14907963

An electrophoretic examination of a urinary mucoprotein which reacts with various viruses.

G E PERLMANN, I TAMM, F L HORSFALL.   

Abstract

A mucoprotein isolated from human urine and possessing the capacity to react with a number of viruses is electrophoretically homogeneous at pH 6.8 and 8.6. After treatment with influenza virus and elimination of its biological activity, the substance remains homogeneous and its electrophoretic mobility is decreased by approximately 20 per cent.

Entities:  

Keywords:  PROTEINS/in urine

Mesh：

Substances：

Year:  1952        PMID： 14907963      PMCID： PMC2212044          DOI： 10.1084/jem.95.1.99

Source DB:  PubMed          Journal:  J Exp Med        ISSN： 0022-1007            Impact factor:   14.307


  7 in total

1.  The electrophoretic properties of plakalbumin.

Authors:  G E PERLMANN
Journal:  J Am Chem Soc       Date:  1949-04       Impact factor: 15.419

2.  Product of interaction between influenza virus enzyme and ovomucin.

Authors:  A GOTTSCHALK; P E LIND
Journal:  Nature       Date:  1949-08-06       Impact factor: 49.962

3.  The egg white inhibitor of influenza virus hemagglutination; preparation and properties of semipurified inhibitor.

Authors:  F LANNI; D G SHARP
Journal:  J Biol Chem       Date:  1949-07       Impact factor: 5.157

4.  N-substituted isoglucosamine released from mucoproteins by the influenza virus enzyme.

Authors:  A GOTTSCHALK
Journal:  Nature       Date:  1951-05-26       Impact factor: 49.962

5.  The egg white inhibitor of influenza virus hemagglutination. V. Electrophoretic studies.

Authors:  D G SHARP; F LANNI; Y T LANNI; T Z CSAKY; J W BEARD
Journal:  Arch Biochem       Date:  1951-02

6.  Enzymatic dephosphorylation of ovalbumin and plakalbumin.

Authors:  G E PERLMANN
Journal:  Nature       Date:  1950-11-18       Impact factor: 49.962

7.  A mucoprotein derived from human urine which reacts with influenza, mumps, and Newcastle disease viruses.

Authors:  I TAMM; F L HORSFALL
Journal:  J Exp Med       Date:  1952-01       Impact factor: 14.307
  7 in total
  10 in total

1.  [Immuno-electrophoretic study of uromucoid].

Authors:  J P VAERMAN; J F HEREMANS
Journal:  Experientia       Date:  1959-06-15

2.  [The tau-fraction in cerebrospinal fluid].

Authors:  D PETTE; I STUPP
Journal:  Klin Wochenschr       Date:  1960-02-01

3.  [Nonspecific inhibitory factors against influenza viruses in the normal serum of guinea pigs].

Authors:  H LIPPELT; W WIRTH
Journal:  Arch Gesamte Virusforsch       Date:  1959

4.  The proteins of normal urine.

Authors:  G H GRANT
Journal:  J Clin Pathol       Date:  1957-11       Impact factor: 3.411

5.  Biocolloids of urine in health and in calculous disease. II. Electrophoretic and biochemical studies of a mucoprotein insoluble in molar sodium chloride.

Authors:  W H BOYCE; M SWANSON
Journal:  J Clin Invest       Date:  1955-10       Impact factor: 14.808

6.  Proteins and other biocolloids of urine in health and in calculous disease. I. Electrophoretic studies at pH 4.5 and 8.6 of those components soluble in molar sodium chloride.

Authors:  W H BOYCE; F K GARVEY; C M NORFLEET
Journal:  J Clin Invest       Date:  1954-10       Impact factor: 14.808

7.  The electrophoretic patterns of proteins in synovial fluid and serum in rheumatoid arthritis.

Authors:  G E PERLMANN; M W ROPES; D KAUFMAN; W BAUER
Journal:  J Clin Invest       Date:  1954-03       Impact factor: 14.808

8.  Studies on influenza virus receptor-substance and receptor-substance analogues. I. Preparation and properties of a homogeneous mucoid from the salivary gland of sheep.

Authors:  J F McCREA
Journal:  Biochem J       Date:  1953-08       Impact factor: 3.857

9.  A mucoprotein derived from human urine which reacts with influenza, mumps, and Newcastle disease viruses.

Authors:  I TAMM; F L HORSFALL
Journal:  J Exp Med       Date:  1952-01       Impact factor: 14.307

10.  Studies on the transferrins of adult serum, cord serum, and cerebrospinal fluid. The effect of neuraminidase.

Authors:  W C PARKER; A G BEARN
Journal:  J Exp Med       Date:  1962-01-01       Impact factor: 14.307
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.